As the women’s NCAA March Madness tournament draws to a close, Eli Lilly is aiming for a slam dunk of its own. | As the women ...

Patients are looking to pharmaceutical companies to offer healthcare services beyond just drug development, and, ideally, in ...

Experts warn about unlisted prescription drugs in "natural" performance enhancers that could trigger life-threatening ...

While AI tools offer undeniable benefits, they also risk diminishing our engagement in deep, reflective thinking and learning ...

The campaign played on the growing fascination with artificial intelligence, advertising features such as micro and nano ...

Fool’s campaign highlighted advanced micro sensors on the fictional condoms that initiate vibrations based on the sixth sense ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

Conservative media outlets like Fox News and The Daily Wire say they're experiencing a surge in advertising demand.

Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to ...

Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, emphasized the company’s innovative efforts to improve patient access to necessary medications. He stated that TONIX ONE ...